glp 1 api GLP-1 Agonists and Antagonists Effects of GLP-1 and Other
Description
In Type 2 diabetes, cells are not answering the door
& Kranzler, H
An additional barrier is that plans that cover GLP-1s generally use some type of prior authorization process to limit patient access
We are starting to witness the fruits of that work with dozens of agents in development that will be more efficacious for obesity and its related complications
